Versant Ventures IV, LLC

CIK 1456589 · last filed 2024-04-11

Versant Ventures IV, LLC is a corporate insider who has filed 6 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for CTNM, was dated Apr 11, 2024. Across all open-market trades the lifetime net is +$525.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $14.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$14.41M

Companies

5

Total Filings

6

Lifetime Open-Market Net

$525.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CTNM	10%+ Owner	767,320	$12.82	$9.84M	$0	1	2024-04-11
Oyster Point Pharma, Inc. (OYST) Delisted	10%+ Owner	2,236,888	$11.17	$24.99M	$0	2	2021-05-14
Inari Medical, Inc. (NARI) Delisted	10%+ Owner	164,825	$79.97	$13.18M	$0	1	2020-11-19
BOLD	10%+ Owner	1,760,743	$2.60	$4.58M	$525.0K	1	2016-07-25
Clovis Oncology, Inc. (CLVS) Delisted	10%+ Owner	1,629,667	$0.08	$132.3K	$0	1	2013-06-05

Recent Filings

6 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-04-11	CTNM	Conv (C)	+4,883,652	$0	EDGAR
2021-05-14	Oyster Point Pharma, Inc. (OYST) Delisted	Other (J)	−2,901,222	$0	EDGAR
2021-02-19	Oyster Point Pharma, Inc. (OYST) Delisted	Other (J)	−2,925,000	$0	EDGAR
2020-11-19	Inari Medical, Inc. (NARI) Delisted	Other (J)	−9,070,020	$0	EDGAR
2016-07-25	BOLD	Mixed	+1,806,832	$525.0K	EDGAR
2013-06-05	Clovis Oncology, Inc. (CLVS) Delisted	Other (J)	−1,629,666	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.